Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1995 Jan;21(1):11-7.
doi: 10.1007/BF02425148.

Reduction of ventilator settings allowed by intravenous oxygenator (IVOX) in ARDS patients

Affiliations
Clinical Trial

Reduction of ventilator settings allowed by intravenous oxygenator (IVOX) in ARDS patients

J P Mira et al. Intensive Care Med. 1995 Jan.

Abstract

Objective: To evaluate the possibility of reducing ventilator settings to "safe" levels by extrapulmonary gas exchange with IVOX in ARDS patients.

Design: Uncontrolled open clinical study.

Setting: Medical Intensive Care Unit of a University Hospital.

Patients: 6 patients with ARDS who entered into IVOX phase II clinical trials.

Interventions: The end-point of this study was to reduce ventilator settings from the initial values, recorded on the day of inclusion, to the following: peak inspiratory pressure < 40 cmH2O, mean airway pressure < 25 cmH2O and tidal volume < 10 ml/kg. Trials to achieve this goal were made on volume-controlled ventilation within the 24 h before and after IVOX insertion. Comparison of the results achieved during these trials used Wilcoxon test.

Results: Before IVOX implantation reduction of ventilator settings was not possible in the 6 patients, despite a non-significant increase in PaO2/FIO2 was achieved. IVOX permitted significant decrease in PaCO2 (from 60.5 +/- 15 to 52 +/- 11 mmHg; p = 0.02) before any modification of the ventilatory mode. After IVOX insertion, a significant decrease of the ventilator settings was performed: peak and mean airway pressures dropped from 44 +/- 10 to 36.8 +/- 6.7; p = 0.02 and from 26.3 +/- 5.6 to 22.5 +/- 3.9 cmH2O; p = 0.02, respectively. Concommitantly, PaCO2 remained unchanged and PaO2/FIO2 increased significantly from 93 +/- 28 to 117 +/- 52; p = 0.04. The interruption of oxygen flow on IVOX was associated with a slight decrease of the oxygen variables. Tolerance of IVOX was satisfactory. However, a significant decrease both in cardiac index and in pulmonary wedge pressures (from 4.5 +/- 1.2 to 3.4 +/- 9; p = 0.03 and from 16 +/- 5 to 11 +/- 2; p = 0.04, respectively) was observed.

Conclusion: Gas exchange achieved by IVOX allowed reduction of ventilator settings in 6 ARDS patients in whom previous attempts have failed. CO2 removal by the device, may explain these results. Efficacy of IVOX on arterial oxygenation was uncertain.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am Rev Respir Dis. 1988 May;137(5):1159-64 - PubMed
    1. ASAIO Trans. 1991 Jul-Sep;37(3):M411-3 - PubMed
    1. Chest. 1984 Jul;86(1):58-66 - PubMed
    1. Am Rev Respir Dis. 1985 Sep;132(3):485-9 - PubMed
    1. Am Rev Respir Dis. 1988 Sep;138(3):720-3 - PubMed

Publication types